Hib-DTP-hepatitis B-poliovirus vaccine - Panacea Biotec
Alternative Names: DTwP-HepB-Hib-IPV-vaccine; Easysix; Fully liquid hexavalent DTwP-HepB-Hib-IPV vaccine - Panacea Biotec; Haemophilus-influenzae-type-b-hepatitis-B-poliovirus-vaccineLatest Information Update: 13 Nov 2018
At a glance
- Originator Panacea Biotec
- Class Bacterial vaccines; Haemophilus vaccines; Hepatitis B vaccines; Influenza virus vaccines; Toxoids; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Poliomyelitis; Tetanus
Most Recent Events
- 09 Oct 2018 Serum Institute of India plans a phase I trial for Healthy volunteers (In infants) in India , (CTRI2018-10-015875)
- 19 Jan 2018 Hib-DTP-hepatitis B-poliovirus vaccine licensed to Serum Institute of India in India
- 18 Jan 2018 Launched for Diphtheria (In infants, Prevention) in India (IM) before Jan 2018